業績

2023

原著論文

1. Linked color imaging provides enhanced visibility with a high color difference in upper gastrointestinal neoplasms. Dohi O, Ono S, Kawada K, Kitamura S, Hatta W, Hori S, Kanzaki M, Murao T, Yagi N, Sasaki F, Hashiguchi K, Oka S, Katada K, Shimoda R, Mizukami K, Suehiro M, Takeuchi T, Katsuki S, Tsuda M, Naito Y, Kawano T, Haruma K, Ishikawa H, Mori K, Kato M and LCI-FIND TRIAL Group. J Gastroenterol Hepatol, 38(1)79-86, 2023
2. Predictive factors of the clinical efficacy of ustekinumab in patients with refractory Crohn's disease: tertiary centers experience in Japan. Esaki M, Ihara Y, Tominaga N, Takedomi H, Tsuruoka N, Akutagawa T, Yukimoto T, Kawasaki K, Umeno J, Torisu T, Sakata Y. Int J Colorectal Dis. 38(1):57, 2023
3. Effectiveness of endoscopic resection for colorectal neoplasms in ulcerative colitis: a multicenter registration study. Hirai M, Yanai S, Kunisaki R, Nishio M, Watanabe K, Sato T, Ishihara S, Anzai H, Hisabe T, Yasukawa S, Maeda Y, Takishima K, Ohno A, Shiga H, Uraoka T, ItoiY, Ogata H, Takabayashi K, Yoshida N, Saito Y, Takamaru H,Tsuruoka N, Hisamatsu T, Matsumoto T.  Kawasaki K, Esaki M.  Gastrointest Endosc. 98(5):806-812, 2023
4. Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study. Kakiuchi T, Matsuo M, Endo H, Sakata Y, Esaki M, Noda T, Imamura I, Hashiguchi K, Ogata S, Fujioka Y, Hanada K, Fukuda K, Yoshimura M, Kajiwara T, Yamamoto K, Yamaguchi D, Kawakubo H, Matsunaga T, Sumino M, Matsunaga K, Muro E, Watanabe A, Fujimoto K. J Gastroenterol, 58(3)196-204, 2023
5. Continuous use of antithrombotic medications during peri-endoscopic submucosal dissection period for colorectal lesionsA propensity score matched study. Kawasaki K, Torisu T, Esaki M, Eizuka M, Kawatoko S, Kumei T, Hirai M, Kondo M, Fujioka S, Fuyuno Y, Matsuno Y, Umeno J, Moriyama T, Kitazono T, Sugai T, Matsumoto T. J Gastroenterol Hepatol 38(6):955-961, 2023
6. Clinical Guidelines for Diagnosis and Management of Juvenile Polyposis Syndrome in Children and Adults-Secondary Publication. Matsumoto T, Umeno J, Jimbo K, Arai M, Iwama I, Kashida H, Kudo T, Koizumi K, Sato Y, Sekine S, Tanaka S, Tanakaya K, Tamura K, Hirata K, Fukahori S, Esaki M, Ishikawa H, Iwama T, Okazaki Y, Saito Y, Matsuura N, Mutoh M, Tomita N, Akiyama T, Yamamoto T, Ishida H, Nakayama Y. J Anus Rectum Colon 7(2):115-125, 2023
7. Machine learning-based model for prediction and feature analysis  of recurrence in pancreatic neuroendocrine tumors G1/G2.  Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y. J Gastroenterol ;58:586-597, 2023
8. Gut-spine axis: a possible correlation between gut microbiota and spinal degenerative diseases. Morimoto T, Kobayashi T, Kakiuchi T, Esaki M, Tsukamoto M, Yoshihara T, Hirata H, Yabuki S, Mawatari M. Front Microbiol 14:1290858, 2023
9. Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis. Naganuma M, Kobayashi T, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Abe T, Hisamatsu T. J Gastroenterol 58(12):1198-1210, 2023
10. Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021. *Nakase H, Esaki M, Hirai F, Kobayashi T, Matsuoka K, Matsuura M, Naganuma M, Saruta M, Tsuchiya K, Uchino M, Watanabe K, Hisamatsu T. J Gastroenterol 58(4):313-345, 2023.
11. Computer-aided diagnosis of early-stage colorectal cancer using nonmagnified endoscopic white-light images (with videos). Nemoto D, Guo Z, Katsuki S, Takezawa T, Maemoto R, Kawasaki K, Inoue K, Akutagawa T, Tanaka H, Sato K, Omori T, Takanashi K, Hayashi Y, Nakajima Y, Miyakura Y, Matsumoto T, Yoshida N, Esaki M, Uraoka T, Kato H, Togashi K.  Gastrointest Endosc. 2023 Jul;98(1):90-99.e4. doi: 10.1016/j.gie.2023.01.050. Epub 2023 Feb 3.
12. Novel mechanisms by which benralizumab suppresses IgE expression in human B cells in humanized mice. Nunomura S, Ito R, Nanri Y, Ohno Y, Honda Y, Takedomi H, Izuhara K.  Allergy;78:3271-3273, 2023
13. Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway. Nunomura S, Uta D, Kitajima I, Nanri Y, Matsuda K, Ejiri N, Kitajima M, Ikemitsu H, Koga M, Yamamoto S, Honda Y, Takedomi H, Andoh T, Conway SJ, Izuhara K. Cell Rep, 42(1)111933, 2023
14. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey. Nakase H, Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Takeuchi K, Tamura S, Kinjo F, Ueno N, Naganuma M, Watanabe K, Moroi R, Nishimata N, Motoya S, Kurahara K, Takahashi S, Maemoto A, Sakuraba H, Saruta M, Tominaga K, Hisabe T, Tanaka H, Terai S, Hiraoka S, Takedomi H, Narimatsu K, Endo K, Nakamura M, Hisamatsu T. J Gastroenterol ;58:205-216, 2023
15. A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study. Saito D, Hirai F, Uchiyama K, Takagi T, Naito Y, Takatsu N, Tanabe H, Kishimoto M, Matsuura M, Miyoshi J, Watanabe K, Esaki M, Naganuma M, Hisamatsu T. Endosc Int Open 11(5):E504-E512, 2023
16.  An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan. Yoshida N, Hayashi Y, Togo D, Oka S, Takada K, Fukunaga S, Morita Y, Hayashi T, Kozuka K, Tsuji Y, Murakami T, Yamamura T, Komeda Y, Takeuchi Y, Shinmura K, Fukuda H, Yoshii S, Ono S, Katsuki S, Kawashima K, Nemoto D, Yamamoto H, Saito Y, Tamai N, Iwao A, Itoi Y, Tsuji S, Inagaki Y, Inada Y, Soga K, Hasegawa D, Murakami T, Yoriki H, Fukumoto K, Motoyoshi T, Nakatani Y, Sano Y, Iguchi M, Fujii S, Ban H, Harada K, Okamoto K, Nishiyama H, Sasaki F, Mizukami K, Shono T, Shimoda R, Miike T, Yamaguchi N.  Clin Gastroenterol Hepatol. doi: 10.1016/j.cgh.2023.09.012. Online ahead of print.
17. Long-term Survival After Endoscopic Resection For Gastric Cancer: Real-world Evidence From a Multicenter Prospective Cohort. Suzuki H, Ono H, Hirasawa T, Takeuchi Y, Ishido K, Hoteya S, Yano T, Tanaka S, Toya Y, Nakagawa M, Toyonaga T, Takemura K, Hirasawa K, Matsuda M, Yamamoto H, Tsuji Y, Hashimoto S, Yuki M, Oyama T, Takenaka R, Yamamoto Y, Naito Y, Yamamoto K, Kobayashi N, Kawahara Y, Hirano M, Koizumi S, Hori S, Tajika M, Hikichi T, Yao K, Yokoi C, Ohnita K, Hisanaga Y, Sumiyoshi T, Kitamura S, Tanaka H, Shimoda R, Shimazu T, Takizawa K, Tanabe S, Kondo H, Iishi H, Ninomiya M, Oda I; J-WEB/EGC group. Clin Gastroenterol Hepatol, 21(2)307-318.e2, 2023
18. J-COMBAT study group. Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study. Watanabe K, Nojima M, Nakase H, Sato T, Matsuura M, Aoyama N, Kobayashi T, Sakuraba H, Nishishita M, Yokoyama K, Esaki M, Hirai F, Nagahori M, Nanjo S, Omori T, Tanida S, Yokoyama Y, Moriya K, Maemoto A, Handa O, Ohmiya N, Tsuchiya K, Shinzaki S, Kato S, Uraoka T, Tanaka H, Takatsu N, Nishida A, Umeno J, Nakamura M, Mishima Y, Fujiya M, Tsuchida K, Hiraoka S, Okabe M, Toyonaga T, Matsuoka K, Andoh A, Hirota Y, Hisamatsu T. J Gastroenterol 58(10):1015-1029, 2023
19. Safety and efficacy of sedation during emergency endoscopy for upper gastrointestinal bleeding: A propensity score matching analysis. *Yamaguchi D, Nagatsuma G, Sakata Y, Mizuta Y, Nomura T, Jinnouchi A, Gondo K, Asahi R, Ishida S, Kimura S, Fujimoto S, Shimakura A, Jubashi A, takeuchi Y, Ikeda K, Tanaka Y, Yoshioka W, Hino N, Morisaki T, Ario K, Tsunada S, Esaki M. Dig Dis Sci, 68(4)1426-1434, 2023
20.  Impact of an artificial intelligence-aided endoscopic diagnosis system on improving endoscopy quality for trainees in colonoscopy: Prospective, randomized, multicenter study. Yamaguchi D, Shimoda R, Miyahara K, Yukimoto T, Sakata Y, Takamori A, Mizuta Y, Fujimura Y, Inoue S, Tomonaga M, Ogino Y, Eguchi K, Ikeda K, Tanaka Y, Takedomi H, Hidaka H, Akutagawa T, Tsuruoka N, Noda T, Tsunada S, Esaki M. Dig Endosc. 2023 Apr 20, 2023
21. 当院で経験した潰瘍性大腸炎関連腫瘍の臨床像に関する検討. 坂田 資尚, 武富 啓展, 鶴岡 ななえ, 島村 拓弥, 行元 崇浩, 芥川 剛至, 下田 良, 江崎 幹宏. 日本大腸検査学会雑誌(1344-1639)39巻2号 Page112-120, 2023
22. 【分類不能腸炎(IBDU)の現状と将来展望】非特異性多発性小腸潰瘍症診断における尿中プロスタグランジンE主要代謝産物(PGE-MUM)の有用性. 松野 雄一, 梅野 淳嗣, 鳥巣 剛弘, 冬野 雄太, 岡本 康治, 安川 重義, 平井 郁仁, 渡辺 憲治, 細江 直樹, 河内 修司, 蔵原 晃一, 八尾 恒良, 松本 主之, 江﨑 幹宏. 胃と腸 58(6):773-781, 2023

 総説

1. Clinical impact of endoscopic evaluation of the small bowel in Crohn's disease. Esaki M, Sakata Y. Digestion, 104(1)51-57, 2023
2.  Recent topics in the pathophysiology and medical management of inflammatory bowel disease.  Esaki M, Saruta M. Digestion, 104(1)5-6, 2023
3. 【 考える画像診断が身につく】全消化管(Case 3). 芥川 剛至, 沖井 詩織, 島村 拓弥, 相島 慎一, 江﨑 幹宏. 胃と腸増刊号読影問題集応用と発展2023(0536-2180)58巻10号 Page1434-1437, 2023
4. 【考える画像診断が身につく】大腸(Case 11)(解説). 芥川 剛至, 江﨑 幹宏. 胃と腸増刊号読影問題集基本と応用2023(0536-2180)58巻4号 Page567-569(2023.04)
5.  【炎症性腸疾患に対する検査法の進歩】内視鏡の進歩がもたらしたIBD診療の新たな展開. 江﨑 幹宏, 芥川 剛至, 坂田 資尚.  日本消化器病学会雑誌(0446-6586)120巻11号 Page880-887(2023.11)
6. 小腸疾患診断におけるカプセル内視鏡の有用性と限界.  江﨑 幹宏, 芥川 剛至, 吉田 雄一朗, 武富 啓展, 島村 拓弥, 行元 崇浩, 鶴岡 ななえ, 坂田 資尚, 藤岡 審, 川崎 啓祐, 梅野 淳嗣, 鳥巣 剛弘, 下田 良.  胃と腸 小腸画像診断のトピックス58(11): 1451-14, 2023
7.  【水・電解質異常と輸液管理】在宅栄養療法.  島村拓弥、江﨑幹宏.  臨床と研究 100(7):840-844, 2023
8. 【大腸T1癌の診断と治療-内視鏡医・外科医・病理医のクロストーク-】診断 大腸T1癌の内視鏡診断 通常観察および色素内視鏡観察(解説).  下田 良, 芥川 剛至, 坂田 資尚, 鶴岡 ななえ, 江﨑 幹宏.  消化器内視鏡(0915-3217)35巻1号 Page22-28(2023.01)
9.  【考える画像診断が身につく】小腸(Case 3)(解説). 下田 良, 芥川 剛至, 武富 啓展, 青木 茂久, 江﨑 幹宏.  胃と腸増刊号読影問題集応用と発展2023(0536-2180)58巻10号 Page1346-1349(2023.10)
10. 潰瘍性大腸炎診療におけるバイオマーカーの有用性.  武富啓展、江﨑幹宏.  日本大腸肛門病学会雑誌(0047-1801)76巻10号 Page559-566, 2023
11. 【解剖生理も、最新の治療も、患者ケアも 決定版!まるごと知りたい消化管】(5章)するっと理解!小腸・大腸のすべて 疾患編 過敏性腸症候群. 鶴岡 ななえ, 江﨑幹宏.  消化器ナーシング(2434-4575)2023秋季増刊 Page170-171, 2023
12. 【解剖生理も、最新の治療も、患者ケアも 決定版!まるごと知りたい消化管】(5章)するっと理解!小腸・大腸のすべて 疾患編 感染性腸炎. 鶴岡 ななえ, 江﨑幹宏.  消化器ナーシング(2434-4575)2023秋季増刊 Page164-165, 2023
13.  【慢性下痢を深く理解する!】慢性下痢の対症療法.  鶴岡 ななえ, 江﨑幹宏.  IBD Research(1881-6533)17巻2号 Page98-101

 症例報告

1. Fecal calprotectin measurement to detect recurrence of solitary juvenile polyps: A case report. Kudoh M, Kakiuchi T, Yoshiura M, Esaki M, Matsuo M. Medicine(Baltimore) 102(43):e35448, 2023
2. Crystal-storing histiocytosis of the rectum possibly associated with chronic mucosal inflammation by ulcerative colitis. Takedomi H, Akutagawa T, Esaki M.  Dig Endosc. 2023 May;35(4):538. doi: 10.1111/den.14526. Epub 2023 Feb 21.
3. Polybacterial Iliopsoas Muscle Abscess as an Indication for Early Diagnosis of Crohn’s Disease  Yamashita S, Nakamura M, Akutagawa T, Nakashima O, Tago M, Esaki M, Yamashita S  Am J Case Rep. 2023; 24: e941399-1–e941399-8. Published online 2023 Nov 30. doi: 10.12659/AJCR.941399
4. 【消化管リンパ増殖性疾患の診断アプローチの基本】経過中に小腸に再発病変を来した狭窄型DLBCLの1例 小腸悪性腫瘍との鑑別を中心に  江崎 幹宏, 芥川 剛至, 下田 良, 行元 崇浩, 島村 拓弥, 板村 英和, 與田 幸恵, 甲斐 敬太, 川崎 啓祐, 木村 晋也, 能城 浩和  胃と腸(0536-2180)58巻7号 Page929-935(2023.07)
5. 乳腺浸潤性小葉癌の広範な消化管転移の1例  坂田 奈津子, 竹内 祐樹, 松永 圭司, 中村 宏彰, 中村 淳, 佐藤 建, 米満 伸久, 坂田 資尚, 江﨑 幹宏  日本消化器病学会雑誌 120(5):416-422, 2023
6.  IBDとの鑑別に苦慮した消化管アミロイドーシスの一例  坂田 資尚  IBD Research 17巻1号 Page47-54, 2023
7. 免疫チェックポイント阻害薬関連大腸炎を繰り返した一例  行元崇浩, 島村拓弥, 永瀬圭, 木戸伸一, 柿木寛明, 江﨑幹宏  佐賀市医師会報 2023.6.1.
8. ひだ集中を伴う偽陥凹型LST-NGの形態をとった大腸環状腺腫の一例  行元崇浩, 芥川剛至, 木戸伸一, 江﨑幹宏  胃と腸58巻, 11号, 1556-1562, 2023 

2022

 原著論文

1. 遠藤 広貴, 水口 昌伸, 鶴岡 ななえ, 白石 良介, 下田 悠一郎, 緒方 伸一, 江﨑幹宏 佐賀県における年代別胃がん対策の現状 日本消化器がん検診学会雑誌 60巻4号 p650-656, 2022
2. Dohi O, Ono S, Shimoda R, et al.  and LCI-FIND TRIAL Group Linked color imaging provides enhanced visibility with a high color difference in upper gastrointestinal neoplasms J Gastroenterol Hepatol. doi: 10.1111/jgh.16018 Online ahead of print. 2022.
3. Haruma K, Kato M, Shimoda R, et al.  Diagnostic ability of linked color imaging in ultraslim endoscopy to identify neoplastic lesions in the upper gastrointestinal tract Endosc Int Open. 10: E88-95, 2022.
4. Kakiuchi T,  Sakata Y, Esaki M, et al. Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study  J Gastroenterol 2022 Online ahead of print.
5. Matsuno Y, Torisu T, Esaki M, et al.  One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study. Intest Res 20(2):260-8, 2022
6. Nagasue T, Hirano A, Esaki M, et al.   The compositional structure of the small intestinal microbila community via balloon-assisted enteroscopy  Digestion103(4):308-18, 2022
7. Nanri Y, Nunomura S, Takedomi H, et al.  A positive loop formed by SOX11 and periostin upregulates TGF-β signals leading to skin fibrosis. J Invest Dermatol. 2022 Dec 27:S0022, 2022
8. Naruse N, Miyahara K, Sakata Y, Tsuruoka N, Shimoda R, Esaki M, et al.  Utility and safety of the self-expandable metallic colonic stent in Japanese patients who received systemic chemotherapy or palliative treatment for obstructive primary advanced colorectal cancer: A retrospective single-center medical chart evaluation JGH Open6(5):324-9, 2022
9. Nunomura S, Uta D, Takedomi H, et al.  Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway Cell Rep. 2022 Dec 29:111933, 2022
10. Shimoda R, Akutagawa T, Tomonaga M, et al.  Estimating colorectal polyp size with a virtual scale endoscope and visual estimation during colonoscopy: Prospective, preliminary comparison of accuracy  Dig Endosc. 34(7):1471-1477.2022.
11. Suzuki H, Ono H, Shimoda R, et al.  J-WEB/EGC group. Long-term Survival After Endoscopic Resection For Gastric Cancer: Real-world Evidence From a Multicenter Prospective Cohort. Clin Gastroenterol Hepatol. 7:S1542-3565(22)00725-X. doi:10.1016/j.cgh.2022.07.029. Online ahead of print.
12. Yamaguchi D, Morisaki T, Sakata Y, Esaki M et al. Usefulness of discharge standards in outpatients undeergoing sedative endoscopy: a propensity score-matched study of the modified post-anesthetic discharge scoring system and the modified Alrete score  BMC Gastroenterol 22(1):445, 2022
13. Yamaguchi D, Nagatsuma G, Sakata Y, Mizuta Y, Esaki M Safety and efficacy of sedation during emergency endoscopy for upper gastrointestinal bleeding: A propensity score matching analysis Dig Dis Sci  2022 Online ahead of print
14. Yamaguchi D, Hidaka H, Akutagawa T, Tsuruoka N, Sakata Y, Shimoda R, Esaki M, et al.  Efficacy of elobixibat as bowel preparation agent for colonoscopy: Prospective, randomized, multi-center study Dig Endosc. 34(1):171-179.2022.

著書

1. 江﨑幹宏 腸管Behcet病, 非特異性多発性小腸潰瘍症 消化器疾患最新の治療2023-24 PP242-245 南江堂

総説

1. 行元崇浩, 蔵原晃一, 江﨑幹宏 血行障害・血管性病変 血管炎症候群 顕微鏡的多発血管炎 日本臨牀80巻増刊号「小腸疾患」, p277-281, 2022
2. 江﨑幹宏 粘膜治癒-炎症性腸疾患の治療ターゲットとしての問題点 胃と腸57(2):121-2, 2022
3. 江﨑幹宏、武富啓展 胃と腸」画像診断用語集2022 分類・定義 腸 Lewis score 胃と腸 57(5):710-11, 2022
4. 坂田資尚, 江﨑幹宏 炎症性腸疾患update-診断・治療の最新治験- 新規治療薬の開発状況 日本臨床 80(3):524-8, 2022
5. 坂田資尚  胃疾患アトラス 改訂版 薬剤性胃潰瘍  消化器内視鏡 34巻 2022 増刊号  p186-7
6. 鶴岡ななえ, 江﨑幹宏  【図説「胃と腸」画像診断用語集2022】疾患 胃 IBDの胃十二指腸病変（図説） 胃と腸 57巻5号 p614

症例報告

1. Kakiuchi T, Takedomi H, Akutagawa T, Tsuruoka N, Sakata Y, Matsuo M. Gastrointestinal bleeding after endoscopic mucosal resection in a case of Peutz-Jeghers syndrome with hypofibrinogenemia: A case report. Front Pediatr. 10:961501. 2022
2.  Kakiuchi T, Akutagawa T  Small intestinal hamartomatous polyp due to Peutz-Jeghers syndrome in middle childhood  Clin Case Rep 10(6):e6001 2022.
3.  Takedomi H, Sakata Y, Tomonaga M, Naruse N, Yukimoto T, Akutagawa T, Tsuruoka N, Shimoda R, Kido S, Esaki M Collagenous Colitis Possibly Associated with Dipeptidyl Peptidase-4 Inhibitor  Intern Med. 61(18):2731-2734. 2022
4. 坂田 資尚, 朝長 道人, 行元 崇浩, 武富 啓展, 鶴岡 ななえ, 成瀬 尚美, 芥川 剛至, 下田 良, 三池 徹, 阪本 雄一郎, 江﨑幹宏 急性出血性直腸潰瘍を発症したCOVID-19重症肺炎の1例 日本大腸検査学会雑誌 38巻2号 p93-101. 2022. 

2021
原著論文

1. Ando K, Fujiya M, Esaki M, et al. A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan. J Gastroenterol 56(12):1062-79. 2021.
2. Degenhardt F, Mayr G, Esaki M, et al. Tranethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associations Hum Mol Genet 30(5):356-69. 2021.
3. Fujimoto S, Tsuruoka N, Esaki M, Sakata Y, Shimoda R, Akutagawa T, Fujimoto K, et al. Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients J Clin Biochem Nutr. 2021 Jan;68(1):95-100. 2021
4. Harada A, Torisu T, Esaki M, et al. Risk of rebleeding in patients with small bowel vascular lesions Intern Med 60(23):3663-9. 2021.
5. Hanashima K, Akutagawa T, et al. Tissue-specific Physical and Biological Microenvironments Modulate the Behavior of Cervical Squamous Cell Carcinoma. Acta Histochem.Cytochem. 2021
6. Hashiguchi M, Sakata Y, Akutagawa T, et al. Collagen Vitrigel Membrane-Coated Nylon Line Prevents Stenosis After Conization of the Cervix Uteri. Tissue Eng Part A. 2021 Dec;27(23-24):1480-1489. doi: 10.1089/ten.TEA. 2021
7. Kakiuchi T, Shimoda R, et al. Stercoral ulcer after Hirschsprung's disease surgery. Clin Case Rep. 2021 Dec 26;9(12):e05239. doi: 10.1002/ccr3.5239. eCollection 2021 Dec.PMID: 34963813. 2021
8. Kakiuchi T, Sakata Y, Esaki M,et al. Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study Helicobacter. 2021 Apr;26(2):e12776. doi: 10.1111/hel.12776. 2021
9. Kawasaki K, Esaki M, et al. Role of barium enema examination for the diagnosis of submucosal invasion depth in T1 colorectal cancers Cancer Imaging. 21(1):66. 2021.
10.  川崎 啓祐, 江﨑 幹宏, 他。内視鏡完全一括切除可能な大腸T1癌の術前診断 注長造影の有用性と限界 胃と腸 56(8): 1035-46, 2021
11. Matsunaga T, Takedomi H, Tsuruoka N, Sakata Y, Shimoda R, Fujimoto K, et al. Lifestyle- and Comorbidity-Related Risk Factors Associated with Prescription of Gastric Acid Secretion Inhibitors to Japanese Patients Who Were Helicobacter pylori Negative and Had No Upper Gastrointestinal Lesions. Digestion. 2021;102(3):437-445. doi: 10.1159/000506153. 2021
12.  Nagase K, Akutagawa T, et al. Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma. J Pathol. 2021
13. Nakamura M, Esaki M, et al. J-POP study group. Tag-less patency capsule for suspected small bowel stenosis: nationwide multicenter prospective study in Japan Dig Endosc 33(1):151-61, 2021
14. Nakamura M, Esaki M, et al. Novel ultrathin double-balloon endoscopy for the diagnosis of small bowel diseases: a multicenter nonrandomized study. Endoscopy 53(8):802-14, 2021
15. 中村 正直, 江﨑 幹宏, 他。本邦における小腸狭窄が疑われた患者に対するタグ非搭載パテンシーカプセル検査の全国多施設前向き調査 Gastroenterological Endoscopy 63(10):2242-52, 2021
16. Nakase H, Esaki M, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 J Gastroenterol 56(6):489-526, 2021
17. Saito Y, Shimoda R, et al. Colonoscopy screening and surveillance guidelines. Dig Endosc. 2021 May;33(4):486-519. doi: 10.1111/den.13972. 2021
18. Shimada F, Fujimoto S, Akutagawa T, Sakata Y, Fujimoto K, Esaki M, et al. Lifestyle- and comorbidity-related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan JGH Open. 2021 Nov 10;5(11):1284-1288. 2021
19. Tanaka T, Esaki M, et al. Gastric microbiota in patients with Helicobacter pylori-negative gastric MALT lymphoma Medicine (Baltimore) 100(38):e27287, 2021
20. Uchino M, Esaki M, et al. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis J Gastroenterol Hepatol 36(4):864-72, 2021
21. Uchino M, Esaki M, et al. Intestinal cancer in patients with Crohn's disease: a systematic review and meta-analysis J Gastroenterol Hepatol, 2021
22. Umeno J, Esaki M, et al. SLCO2A1 gene is the causal gene for both primary hypertrophic osteoarthropathy and hereditary chronic enteropathy J Orthop Translat 28:10-11, 2021
23. Watanabe C, Esaki M, et al. Non-adherence to medications in pregnant ulcerative colitis patients contributes to disease flares and adverse pregnancy outcomes. Dig Dis Sci66(2):577-86, 2021
24. Yamaguchi D, Akutagawa T, Tsuruoka N, Sakata Y, Shimoda R, Esaki M, et al. Efficacy of elobixibat as bowel preparation agent for colonoscopy: Prospective, randomized, multi-center study Dig Endosc doi: 10.1111/den.14010. Online ahead of print. 2021
25. Yamaguchi D, Tsuruoka N, Sakata Y, Akutagawa T, Esaki M, et al. Safety and Efficacy of the Noncessation Method of Antithrombotic Agents after Emergency Endoscopic Hemostasis in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Multicenter Pilot Study Can J Gastroenterol Hepatol.2021 May 21;2021:6672440. doi: 10.1155/2021/6672440. 2021
26. Yoshihara T, Esaki M, et al. Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: a systematic review and meta-analysis J Gastroenterol Hepatol 36(7):1744-53, 2021
27. Zeze K, Esaki M, et al. Adding thiopurine after loss of response to infliximab versus early combination in treating Crohn's disease: a retrospective study Dig Dis Sci 66(9):3124-31 2021

著書

1. 江﨑幹宏 膠原病の消化管病変 消化器疾患最新の治療2021-2022 p225-228 南江堂, 東京 2021
2. 江﨑幹宏 消化管アミロイドーシス 専門医のための消化器病学 p315-319 医学書院, 東京 2021

総説

1. 芥川剛至,江崎幹宏 【炎症性腸疾患診療の新たな展開】クローン病-診断 臨牀と研究. 98巻5号:31(547)-36(552), 2021
2. 芥川 剛至, 朝長 道人, 成瀬 尚美, 武富 啓展, 行元 崇浩, 鶴岡 ななえ, 坂田 資尚, 下田 良, 江﨑 幹宏 【クローン病診療の診断から治療をマスターする】クローン病を疑うときはどのようなときか? 日常診療からクローン病を拾い上げる(解説/特集) 消化器・肝臓内科 10巻4号 Page401-407, 2021
3. 江﨑幹宏 <消化管診断・治療手技の全て2021>小腸 診断 小腸造影（二重造影) 胃と腸 56(5): 686-7, 2021
4. 江﨑幹宏 <消化管診断・治療手技の全て2021>小腸 診断 小腸造影（充満法) 胃と腸 56(5): 684-5, 2021
5. 江﨑幹宏、鷲尾恵万、岡本康治、前畠裕司 治療の実際 NSAIDs起因性小腸粘膜傷害の実態とそのマネージメント 臨床と研究 98(8):1011-3, 2021
6. 江﨑幹宏、武富啓展、芥川剛至 <「胃と腸」式読影問題集-考える画像診断が身につく>読影問題集 小腸(Case 2) 胃と腸 56(9): 1196-1200, 2021
7. 坂田 資尚,江﨑 幹宏 十二指腸内視鏡像からIBDを診断する 消化器内科 3巻9号 Page73-82, 2021
8. 坂田 資尚, 江﨑 幹宏 Image-enhanced endoscopy (IEE) IBD Research 2021年12月号 Vo;.15 No.4 Page 21-27, 2021
9. 関口 正宇,下田 良, 他。 【取りっぱなしにしてませんか?大腸腫瘍の内視鏡治療とサーベイランス-再発させないコツと異時性病変の早期発見】大腸内視鏡スクリーニングとサーベイランスガイドラインの要点 消化器内視鏡 (0915-3217)33巻1号 Page25-32 2021
10. 鶴岡ななえ、江﨑幹宏 【外来における救急診療のポイント】各症状への対応 吐血・下血(解説/特集) 臨床と研究 98巻2号 Page200-204, 2021
11. 山本 博徳, 江﨑 幹宏, 他. クローン病小腸狭窄に対する内視鏡的バルーン拡張術ガイドライン（小腸内視鏡診療ガイドライン追補） Gastroenterological Endoscopy 63(10):2253-75, 2021 

2020
原著論文

1. An Integrated Genomic and Transcriptomic Analysis Reveals Candidates of Susceptibility Genes for Crohn's Disease in Japanese Populations. Kakuta Y, Ichikawa R, Esaki M, et al. Sci Rep. 2020 10(1):10236. doi: 10.1038/s41598-020-66951-5.
2. A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan. Sakata Y, Tsuruoka N, Takedomi H, Akutagawa T, Shimoda R, Esaki M, Fujimoto K. Digestion. 2020;101(3):308-315. doi: 10.1159/000498967.
3. Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array. Okamoto D, Kawai Y, Esaki M, et al. Inflamm Bowel Dis. 2020 Feb 19:izaa033. doi: 10.1093/ibd/izaa033.
4. Mucosal dysbiosis in patients with gastrointestinal follicular lymphoma. Zeze K, Hirano A, Esaki M, et al. Hematol Oncol. 2020 38(2):181-188. doi: 10.1002/hon.2717.
5. Gastrointestinal: Burkitt lymphoma showing multiple tumorous lesions in the gastrointestinal tract. Harada A, Torisu T, Esaki M. J Gastroenterol Hepatol. 2020 35(3):361. doi: 10.1111/jgh.14885.
6. Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease. Matsuno Y, Hirano A, Esaki M, et al. J Gastroenterol Hepatol. 2020 35(3):412-417. doi: 10.1111/jgh.14823.
7. Lifestyle- and Comorbidity-Related Risk Factors Associated with Prescription of Gastric Acid Secretion Inhibitors to Japanese Patients Who Were Helicobacter pylori Negative and Had No Upper Gastrointestinal Lesions. Matsunaga T, Takedomi H, Tsuruoka N, Sakata Y, Shimoda R, et al. Digestion. 2020 25:1-9. doi: 10.1159/000506153.
8. Colon Metastasis of Breast Cancer With a Unique Endoscopic Finding. Takedomi H, Akutagawa T, Sakata Y.Clin Gastroenterol Hepatol. 2020 Jun;18(7):e74. doi: 10.1016/j.cgh.2019.04.014.
9. Recent Trends in Treatment for Colonic Diverticular Bleeding in Japan. Tsuruoka N, Takedomi H, Sakata Y, Shimoda R. Digestion. 2020;101(1):12-17. doi: 10.1159/000504089.
10. An Investigation of Nine Patients with Gastrointestinal Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors. Miyahara K, Takedomi H, Akutagawa T, Sakata Y, et al. Digestion. 2020;101(1):60-65. doi: 10.1159/000504647.
11. Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan. Shimamura T,, Takedomi H, Tsuruoka N, Sakata Y, et al. Digestion. 2020; 101:  557-562. doi: 5:1-6 10.1159/000501309.
12. 大腸内視鏡スクリーニングとサーベイランスガイドライン  斎藤豊，岡志郎，下田良，ほか. 日本消化器内視鏡学会雑誌 62：1519-1560, 2020
13. Cecal Intussusception Diagnosed by Total Colonoscopy in a Child: A Case Report T, Esaki M, Nakayama A, Ichinose F, Matsuo M.Front Pediatr. 8:438, 2020. doi: 10.3389/fped.2020.00438.
14. Intestinal cancer in patients with Crohn's disease: A systematic review and meta-analysis Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.J Gastroenterol Hepatol. 2020 doi: 10.1111/jgh.15229.
15. Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn's Disease: A Retrospective Study K, Hirano A, Torisu T, Esaki M, Moriyama T, Umeno J, Kawasaki K, Fujioka S, Fuyuno Y, Matsuno Y, Kitazono T.Dig Dis Sci. 2020 . doi: 10.1007/s10620-020-06600-z.
16. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysisUchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.J Gastroenterol Hepatol. 2020 doi: 10.1111/jgh.15288.
17. Linked Color Imaging Focused on Neoplasm Detection in the Upper Gastrointestinal Tract: A Randomized Trial. Ono S, Kawada K, Shimoda R, et al. Ann Intern Med.2020 Doi: 10.7326/M19-2561.
18. Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study. Kakiuchi T, Endo H, Sakata Y, Esaki M, et al. Helicobacter Nov 17; e12776. 2020

著書

1. 江﨑幹宏 『放射線性腸炎 好酸球性消化管疾患 非特異的多発性小腸潰瘍』 新臨床内科学 医学書院 東京 2020
2. 坂田資尚 『急性胃炎』 新臨床内科学 医学書院 東京 2020
3. 江﨑幹宏 『腸結核・腸管Behçet病』 今日の診断指針 医学書院 東京 2020
4. 仲瀬裕志, 井上詠, 江﨑幹宏 ほか。 炎症性腸疾患(IBD) 診療ガイドライン2020 改訂第2版

総説

1. 坂田資尚，下田良，藤本一眞 ESDの出血高リスク症例に対する対応と工夫 臨床消化器内科 35：241-248. 2020
2. 江﨑幹宏，芥川剛至，下田良，鶴岡ななえ，坂田資尚，藤本峻 ほか Crohn病の内視鏡 定型病変と非定型病変 消化器内視鏡 32：240-246. 2020
3. 江﨑幹宏, 梅野淳嗣，坂田資尚，吉岡慎一郎 UC経過中にアメーバ性大腸炎を合併した例 IBDクリニカルカンファレンス ２: 5-12, 2020.
4. 鶴岡ななえ，坂田資尚，江﨑幹宏 空腸、回腸、盲腸、結腸、直腸(上) 炎症性疾患 腸管サルコイドーシス 日本臨床 別冊消化管症候群３③Ⅲ, 194-197, 2020
5. 下田良 大腸粘膜下腫瘍：総論 日本臨床 別冊消化管症候群（第3版）Ⅳ 98-101、2020
6. 坂田資尚，岩切龍一 薬剤性消化器疾患の診断 胃,十二指腸 臨床消化器内科 35: 695-701, 2020
7. 坂田資尚 空腸、回腸、盲腸、結腸、直腸(下) 血行障害、血管病変 腸管動静脈奇形、Blue Rubber Bleb Nevus Syndrome  日本臨床 別冊消化管症候群Ⅳ 290-294, 2020
8. 坂田資尚，江崎幹宏  【発熱診療のポイント】発熱と感染症 消化管感染症 臨床と研究 97: 1207-1212, 2020
9. 江崎 幹宏, 田中 貴英, 今津 愛介 【小腸腫瘍アトラス】症例アトラス 悪性リンパ腫 ATL/L(図説/特集) 胃と腸 55巻11号 Page1398-1401, 2020
10. 江崎 幹宏 IBDのスペシャルシチュエーションをどう診るか?(第5回) IBDに伴うがん/悪性腫瘍をどう診るか?(その1) 他臓器がん合併IBDに対する免疫抑制治療、生物学的製剤の使い方(解説) IBD Research 14巻3号 Page204-206, 2020.
11. 江崎 幹宏, 梅野 淳嗣, 平野 敦士, 川崎 啓祐, 松本 主之  【消化管症候群(第3版)-その他の消化管疾患を含めて-】空腸、回腸、盲腸、結腸、直腸(下) 腫瘍 大腸腫瘍 消化管ポリポーシス 若年性ポリポーシス症候群(解説/特集) 本臨床 (0047-1852)別冊消化管症候群IV Page148-151, 2020
12. 鶴岡 ななえ, 坂田 資尚, 江崎 幹宏  【消化管症候群(第3版)-その他の消化管疾患を含めて-】空腸、回腸、盲腸、結腸、直腸(上) 炎症性疾患 腸管サルコイドーシス(解説/特集) 日本臨床 別冊消化管症候群III Page194-197, 2020
13. 江﨑幹宏,冬野雄太,川床慎一郎,保利喜史,芥川剛至  【潰瘍性大腸炎関連腫瘍-診断・治療の現状と課題】潰瘍性大腸炎関連腫瘍に対する内視鏡治療 私はこう考える 胃と腸. 55巻2号:167-169, 2020
14. 江﨑幹宏，芥川剛至，下田良，鶴岡ななえ，坂田資尚，藤本峻，冬野雄太，平野敦士，梅野淳嗣，鳥巣剛弘  【すべてがわかるIBDの内視鏡】Crohn病の内視鏡 定型病変と非定型病変(解説/特集)  消化器内視鏡.32：240-246, 2020
15. 江崎 幹宏 【ここまで明らかになった小腸疾患】小腸の検査方法 小腸X線造影検査(解説/特集) 診断と治療 (0370-999X)108巻1号 Page51-54, 2020
16. 江﨑幹宏, 松本主之 ほか <TOPICS>クローン病診断に有用なカプセル内視鏡所見に関する検討:本邦多施設症例対照研究 INTESTINE 24巻2号 p157-9、2020
17. 江﨑幹宏, 梅野淳嗣, 川床慎一郎 抗腫瘍薬・分子標的薬起因性腸炎 消化器内視鏡 32巻増刊号 p208-9、2020
18. 坂田 資尚, 岩切 龍一 「消化器内視鏡の洗浄・消毒標準化にむけたガイドライン」に基づいた内視鏡診療 臨床消化器内科 35: 7-14、2020
19. 鶴岡 ななえ ディベート 十二指腸腺腫の治療 経過観察の立場から The GI Forefront(1349-9629)15巻2号 Page132-135、2020